Literature DB >> 10592894

Laboratory diagnosis of dengue virus infection by reverse transcriptase polymerase chain reaction (RT-PCR) and IgM-capture enzyme-linked immunosorbent assay (ELISA).

K Yamada1, M Nawa, T Takasaki, S Yabe, I Kurane.   

Abstract

Dengue virus infections are a major public health problem in most tropical and sub-tropical countries of the world. Dengue is occasionally imported by travelers who visit tropical areas and become infected with dengue virus. Laboratory diagnosis is essential for confirming the diagnosis of this virus. For purposes of confirmation, detection of specific IgM by IgM-capture enzyme-linked immunosorbent assay (ELISA) and of dengue virus genome by reverse transcriptase polymerase chain reaction (RT-PCR) have recently been used. In the present study, we tested serum specimens from dengue-suspected Japanese cases, by IgM-capture ELISA, RT-PCR, HI, and virus isolation. Serum samples collected before or on the day of defervescence were positive by RT-PCR, though no PCR-positive samples were obtained after fever day 1. IgM-capture ELISA was positive as early as disease day 4, and all samples but one were IgM-positive when collected on disease day 5 or later. In light of these findings, we recommend that both RT-PCR and IgM-capture ELISA be performed, irrespective of the stage of dengue illness. Combination of RT-PCR and IgM-capture ELISA increases the ability to diagnose dengue virus infection, even in the only that a single serum specimen from the patient is available.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592894

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  8 in total

1.  Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  M Nawa; K I Yamada; T Takasaki; T Akatsuka; I Kurane
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  A Sa-Ngasang; S Anantapreecha; A A-Nuegoonpipat; S Chanama; S Wibulwattanakij; K Pattanakul; P Sawanpanyalert; I Kurane
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.

Authors:  Rajpal Singh Kashyap; Shweta H Morey; Sonali S Ramteke; Nitin H Chandak; Manmohan Parida; Poonam S Deshpande; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

4.  Immunoglobulin A antibody responses in dengue patients: a useful marker for serodiagnosis of dengue virus infection.

Authors:  M Nawa; T Takasaki; M Ito; S Inoue; K Morita; I Kurane
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

5.  Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications.

Authors:  Rajpal S Kashyap; Shweta H Morey; Nitin H Chandak; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-13

6.  Antibody responses determined for Japanese dengue fever patients by neutralization and hemagglutination inhibition assays demonstrate cross-reactivity between dengue and Japanese encephalitis viruses.

Authors:  Ken-Ichiro Yamada; Tomohiko Takasaki; Masaru Nawa; Sadao Yabe; Ichiro Kurane
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

7.  Occurrence of Dengue Virus Infection with Multiple Serotypes in Central Karnataka, India.

Authors:  VinodKumar C Shivaswamy; Prasad B Shivanagowda; Kalappanavar N Kenchappa; Jayasimha V Lakshminarayan
Journal:  J Lab Physicians       Date:  2021-11-23

8.  Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India.

Authors:  Preeti Bharaj; Harendra S Chahar; Anubhav Pandey; Kavita Diddi; Lalit Dar; Randeep Guleria; Sushil K Kabra; Shobha Broor
Journal:  Virol J       Date:  2008-01-09       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.